106 related articles for article (PubMed ID: 25441945)
1. Homology modeling and explicit membrane molecular dynamics simulation to delineate the mode of binding of thiazolidinediones into FFAR1 and the mechanism of receptor activation.
Helal MA; Darwish KM; Hammad MA
Bioorg Med Chem Lett; 2014 Nov; 24(22):5330-6. PubMed ID: 25441945
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
Darwish KM; Salama I; Mostafa S; Gomaa MS; Helal MA
Eur J Med Chem; 2016 Feb; 109():157-72. PubMed ID: 26774923
[TBL] [Abstract][Full Text] [Related]
3. Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus.
Rani L; Grewal AS; Sharma N; Singh S
Mini Rev Med Chem; 2021; 21(4):426-470. PubMed ID: 33100202
[TBL] [Abstract][Full Text] [Related]
4. Multi-conformation dynamic pharmacophore modeling of the peroxisome proliferator-activated receptor γ for the discovery of novel agonists.
Sohn YS; Park C; Lee Y; Kim S; Thangapandian S; Kim Y; Kim HH; Suh JK; Lee KW
J Mol Graph Model; 2013 Nov; 46():1-9. PubMed ID: 24104184
[TBL] [Abstract][Full Text] [Related]
5. Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics.
Atanasio S; Deganutti G; Reynolds CA
J Comput Aided Mol Des; 2020 Nov; 34(11):1181-1193. PubMed ID: 32851580
[TBL] [Abstract][Full Text] [Related]
6. Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs.
Lee MA; Tan L; Yang H; Im YG; Im YJ
Sci Rep; 2017 Dec; 7(1):16837. PubMed ID: 29203903
[TBL] [Abstract][Full Text] [Related]
7. The effect of FFAR1 on pioglitazone-mediated attenuation of palmitic acid-induced oxidative stress and apoptosis in βTC6 cells.
Shen X; Yang L; Yan S; Wei W; Liang L; Zheng H; Cai X
Metabolism; 2014 Mar; 63(3):335-51. PubMed ID: 24360748
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists.
Peng YH; Coumar MS; Leou JS; Wu JS; Shiao HY; Lin CH; Lin WH; Lien TW; Chen X; Hsu JT; Chao YS; Huang CF; Lyu PC; Hsieh HP; Wu SY
ChemMedChem; 2010 Oct; 5(10):1707-16. PubMed ID: 20734309
[TBL] [Abstract][Full Text] [Related]
9. X-ray crystal structure of rivoglitazone bound to PPARγ and PPAR subtype selectivity of TZDs.
Rajapaksha H; Bhatia H; Wegener K; Petrovsky N; Bruning JB
Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1981-1991. PubMed ID: 28499821
[TBL] [Abstract][Full Text] [Related]
10. A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.
Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
Endocrinology; 2009 Feb; 150(2):862-70. PubMed ID: 19147680
[TBL] [Abstract][Full Text] [Related]
11. Mode of peroxisome proliferator-activated receptor γ activation by luteolin.
Puhl AC; Bernardes A; Silveira RL; Yuan J; Campos JL; Saidemberg DM; Palma MS; Cvoro A; Ayers SD; Webb P; Reinach PS; Skaf MS; Polikarpov I
Mol Pharmacol; 2012 Jun; 81(6):788-99. PubMed ID: 22391103
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of fatty acid activation of FFAR1.
Kumari P; Inoue A; Chapman K; Lian P; Rosenbaum DM
Proc Natl Acad Sci U S A; 2023 May; 120(22):e2219569120. PubMed ID: 37216523
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and molecular docking investigation of benzhydrol- and indole-based dual PPAR-γ/FFAR1 agonists.
Darwish KM; Salama I; Mostafa S; Gomaa MS; Khafagy ES; Helal MA
Bioorg Med Chem Lett; 2018 May; 28(9):1595-1602. PubMed ID: 29615345
[TBL] [Abstract][Full Text] [Related]
14. Computational Insights into Molecular Activation and Positive Cooperative Mechanisms of FFAR1 Modulators.
Teng D; Chen J; Li D; Wu Z; Li W; Tang Y; Liu G
J Chem Inf Model; 2020 Jun; 60(6):3214-3230. PubMed ID: 32338509
[TBL] [Abstract][Full Text] [Related]
15. FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.
Kristinsson H; Smith DM; Bergsten P; Sargsyan E
Endocrinology; 2013 Nov; 154(11):4078-88. PubMed ID: 24035997
[TBL] [Abstract][Full Text] [Related]
16. Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway.
Ou HY; Wu HT; Lu FH; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Mol Endocrinol; 2014 Oct; 53(2):165-74. PubMed ID: 25008074
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
[TBL] [Abstract][Full Text] [Related]
18. A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: design and synthesis of benzylpyrazole acylsulfonamides.
Rikimaru K; Wakabayashi T; Abe H; Imoto H; Maekawa T; Ujikawa O; Murase K; Matsuo T; Matsumoto M; Nomura C; Tsuge H; Arimura N; Kawakami K; Sakamoto J; Funami M; Mol CD; Snell GP; Bragstad KA; Sang BC; Dougan DR; Tanaka T; Katayama N; Horiguchi Y; Momose Y
Bioorg Med Chem; 2012 Jan; 20(2):714-33. PubMed ID: 22209730
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design.
Montanari R; Saccoccia F; Scotti E; Crestani M; Godio C; Gilardi F; Loiodice F; Fracchiolla G; Laghezza A; Tortorella P; Lavecchia A; Novellino E; Mazza F; Aschi M; Pochetti G
J Med Chem; 2008 Dec; 51(24):7768-76. PubMed ID: 19053776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
